3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Endometrial Neoplasms
13
Uterine Cervical Neoplasms
4
Ovarian Neoplasms
3
Vulvar Neoplasms
2
Squamous Intraepithelial Lesions
2
Rectal Neoplasms
2
Peritoneal Neoplasms
2
Neoplasms
2
Fallopian Tube Neoplasms
2
Esophageal Neoplasms
2
Breast Neoplasms
2
Anus Neoplasms
2
Acquired Immunodeficiency Syndrome
2
Vaginal Neoplasms
1
Urinary Bladder Neoplasms
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sezary Syndrome
1
Pseudomyxoma Peritonei
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Papillomavirus Infections
1
Pancreatic Neoplasms
1
Neuroblastoma
1
Myeloproliferative Disorders
1
Mycosis Fungoides
1
Multiple Myeloma
1
Interventions
Fluorouracil
3
Watchful Waiting
2
Taxes
2
Polymerase Chain Reaction
2
Paclitaxel
2
Light Coagulation
2
Imiquimod
2
Cisplatin
2
Carboplatin
2
cabozantinib
1
Vorinostat
1
Triage
1
Specimen Handling
1
Remote Patient Monitoring
1
Radiotherapy
1
Radiation
1
Platinum
1
Observation
1
Nivolumab
1
Mass Screening
1
Magnetic Resonance Spectroscopy
1
Laser Therapy
1
Isotretinoin
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Histological Techniques
1
Electrocoagulation
1
Coal Tar
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
HIV Infections
×
Observation
×
Gynecologic
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts